Skip to main content
. 2022 Jun 2;15:123. doi: 10.1186/s12920-022-01279-9

Table 2.

Biological characteristics

Subgroup Cases (n = 38) n (%) Controls (n = 53) n (%) P-value
PSA during this study (ng/ml)
 ≤ 4.0 37 (70)
 4.1–10.0 11 (21)
 10.1–20.0 3 (6)
 > 20 2 (3)
Mean (SD) 4.16 (4.70)
PSA at diagnosis (ng/ml)
 ≤ 4.0 0 (0)
 4.1–10.0 3 (7.9)
 10.1–20.0 4 (10.5) < 0.001
 > 20 31 (81.6)
Mean (SD) 627.85 (1153.42)
 Gleason score
 < 7 10 (26.3)
 7 23 (60.5) < 0.001
 > 7 5 (13.2)

statistically significant, p ≤ 0.05 is shown in bold

PSA prostate specific antigen, SD standard deviation